Cardiovascular Systems, Inc. Data for Treatment of Peripheral Arterial Disease in Office-Based Lab Settings Presented at Society for Interventional Radiology Meeting

ST. PAUL, Minn.--(BUSINESS WIRE)--Cardiovascular Systems, Inc. (CSI) (Nasdaq: CSII), today announced results from a study of patients treated for peripheral arterial disease (PAD) with CSI’s Diamondback™ Orbital Atherectomy System in a non-hospital setting. Dr. Warren Swee, South Florida Vascular Associates, Coconut Creek, Fla. discussed his analysis of data demonstrating device safety and efficacy treating calcified lesions in the office-based lab (OBL) setting at the Society for Interventional Radiology (SIR) Annual Scientific Meeting in San Francisco.